Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | ESR1 | P03372 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 4/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 5/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | S100A4 | P26447 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29842660 | 1.00 | LMNA (0.39) | LMNAESR1THRBTDP1MEN1 | |
| SCHEMBL30807114 | 1.00 | LMNA (0.39) | LMNAESR1THRBTDP1MEN1 | |
| SCHEMBL132981 | 1.00 | LMNA (0.39) | LMNAESR1THRBTDP1MEN1 | |
| SCHEMBL9927121 | 1.00 | LMNA (0.39) | LMNAESR1THRBTDP1MEN1 | |
| SCHEMBL17928303 | 1.00 | LMNA (0.39) | LMNAESR1THRBTDP1MEN1 | |
| SCHEMBL29511972 | 1.00 | LMNA (0.39) | LMNAESR1THRBTDP1MEN1 | |
| SCHEMBL12016691 | 1.00 | LMNA (0.39) | LMNAESR1THRBTDP1MEN1 | |
| SCHEMBL29865503 | 1.00 | LMNA (0.39) | LMNAESR1THRBTDP1MEN1 | |
| SCHEMBL10299019 | 0.95 | LMNA (0.42) | LMNAESR1TDP1MEN1KMT2A | |
| SCHEMBL2969076 | 0.95 | KDM4E (0.37) | LMNAESR1THRBTDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023224370-A1 | COMPOUND, COATING COMPOSITION COMPRISING SAME, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND METHOD FOR MANUFACTURING SAME | 주식회사 엘지화학 | 2023-11-23 | — | — | WO | disclosed |
| US-11696496-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| US-11696496-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| EP-3005433-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2023-02-22 | — | — | EP | disclosed |
| US-11535640-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2022-12-27 | — | — | US | disclosed |
| US-11136343-B2 | Binuclear metal complexes for use as emitters in organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2021-10-05 | — | — | US | disclosed |
| US-11024815-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2021-06-01 | — | — | US | disclosed |
| EP-3658564-B1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2021-05-19 | — | — | EP | disclosed |
| US-10889604-B2 | Binuclear and trinuclear metal complexes composed of two inter-linked tripodal hexadentate ligands for use in electroluminescent devices | MERCK PATENT GMBH | 2021-01-12 | — | — | US | disclosed |
| EP-3117470-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2020-12-23 | — | — | EP | disclosed |
| WO-2012013271-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2012-02-02 | — | — | WO | disclosed |
| EP-2366752-A2 | New materials for electroluminescence and use of same | Merck Patent GmbH (DE) | 2011-09-21 | — | — | EP | disclosed |
| US-20110108818-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-05-12 | — | — | US | disclosed |
| US-20110108818-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-05-12 | — | — | US | disclosed |
| EP-2251396-A2 | Mixture of organic emission-capable semiconductors and matrix materials, use of same and electronic components containing same | Merck Patent GmbH (DE) | 2010-11-17 | — | — | EP | disclosed |
| WO-2010108579-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2010-09-30 | — | — | WO | disclosed |
| US-7776455-B2 | Organic electronic devices | MERCK PATENT GMBH (DE) | 2010-08-17 | — | — | US | disclosed |
| US-7776455-B2 | Organic electronic devices | MERCK PATENT GMBH (DE) | 2010-08-17 | — | — | US | disclosed |
| US-20070170419-A1 | Organic electronic devices | MERCK PATENT GMBH (DE) | 2007-07-26 | — | — | US | disclosed |
| US-20070170419-A1 | Organic electronic devices | MERCK PATENT GMBH (DE) | 2007-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11024815-B2 | Metal complexes | EXOC4, EXOC3, TIMCC | LMNA 4536/4885ESR1 2309/4885THRB 3931/4885 |
| US-10889604-B2 | Binuclear and trinuclear metal complexes composed of two inter-linked tripodal hexadentate ligands for use in electroluminescent devices | PARN, PUF60, PARG | LMNA 2692/4885ESR1 1689/4885THRB 3570/4885 |
| US-11535640-B2 | Metal complexes | IMMT, MCU, SOD1 | LMNA 4756/4885ESR1 1140/4885THRB 4644/4885 |
| US-11136343-B2 | Binuclear metal complexes for use as emitters in organic electroluminescent devices | AP2M1, MCU, AP3M1 | LMNA 3190/4885ESR1 879/4885THRB 4642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.